Table 2 Generalized linear model of blood loss after vaginal birth by OXTR genotype (rs53576)Â accounting for relevant covariates
From: Oxytocin receptor single nucleotide polymorphism predicts atony-related postpartum hemorrhage
|  | Total blood loss volume β(95%CI) |
|---|---|
Model 1 | |
 OXTR A/G & A/A (vs. GG) | 203.78 (6.01 – 401.54)* |
 European Ancestry vs. None | 40.77 (-219.51 – 301.07) |
Model 2 | |
  OXTR A/G & A/A (vs. GG) | 300.76 (126.61 – 474.92)*** |
  European Ancestry vs. None | 110.21 (-112.84 – 333.27) |
  Oxytocin dosage during labor (per Unit) | 24.20 (7.64 – 40.76)** |
Model 3 | |
  OXTR A/G & A/A (vs. GG) | 275.24 (96.33 – 454.16)** |
  European Ancestry vs. None | 147.18 (-79.13 – 373.49) |
  Oxytocin dosage during labor (per Unit) | 20.85 (3.64 – 38.07)* |
  Primiparity | 125.77 (-68.33 – 319.88) |
Model 4 | |
  OXTR A/G & A/A (vs. GG) | 278.09 (100.36 – 455.83)** |
  European Ancestry vs. None | 133.36 (-94.05 – 360.77) |
  Oxytocin dosage during labor (per Unit) | 20.68 (-3.08 – 38.28)* |
  Primiparity | 95.89 (-124.97 – 316.76) |
  Genital tract lacerations | 29.46 (-55.09 – 127.26) |
Model 5 | |
  OXTR A/G & A/A (vs. GG) | 275.16 (96.92 – 453.40)** |
  European Ancestry vs. None | 148.99 (-75.19 – 373.18) |
  Oxytocin dosage during labor (per Unit) | 21.25 (3.74 – 38.75)* |
  Primiparity | 21.25 (3.74 – 38.75)* |
  Active Management of Third Stage Labor | -33.04 (-259.81 – 193.72) |